We performed qRT-PCR assays to assess the OXCT1-AS1 expression level in GBM cell lines, and the expression levels of OXCT1-AS1 were upregulated in GBM cells compared with those in NHA cells (Fig. 4a). The gene discussed is OXCT1; the disease is glioblastoma.